Liz Highleyman

San Francisco

Medical Journalist and Editor at Freelance

Science Editor at Cancer Health

Science Editor at POZ

Articles

Cooling or Compressing Hands During Chemo Can Prevent Neuropathy

2 weeks ago | cancerhealth.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.
Cooling or Compressing Hands During Chemo Can Prevent Neuropathy

2 weeks ago | realhealthmag.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.
Cooling or Compressing Hands During Chemo Can Prevent Neuropathy

2 weeks ago | tusaludmag.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.
NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment

2 weeks ago | realhealthmag.com | Liz Highleyman

The Trump administration has rescinded hundreds of National Institutes of Health (NIH) research grants, including many that involve HIV and sexually transmitted infections (STIs). Scientists and advocates have filed a lawsuit to stop the cuts, but prospects for continued funding remain uncertain.
NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment

2 weeks ago | tusaludmag.com | Liz Highleyman

The Trump administration has rescinded hundreds of National Institutes of Health (NIH) research grants, including many that involve HIV and sexually transmitted infections (STIs). Scientists and advocates have filed a lawsuit to stop the cuts, but prospects for continued funding remain uncertain.
Can Broadly Neutralizing Antibodies Keep HIV in Remission?

2 weeks ago | realhealthmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) appeared to help keep HIV under control after stopping antiretroviral therapy and may play a role in long-term remission, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). In the RIO study, three quarters of men who received the bnAbs 3BNC117-LS and 10-1074-LS did not experience viral rebound five months after discontinuing their antiretrovirals, and a third were still in remission at 18 months.
Can Broadly Neutralizing Antibodies Keep HIV in Remission?

2 weeks ago | poz.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) appeared to help keep HIV under control after stopping antiretroviral therapy and may play a role in long-term remission, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). In the RIO study, three quarters of men who received the bnAbs 3BNC117-LS and 10-1074-LS did not experience viral rebound five months after discontinuing their antiretrovirals, and a third were still in remission at 18 months.
Federal Health Department Reorganizes and Slashes Staff

3 weeks ago | poz.com | Liz Highleyman

In what is being described as a “bloodbath,” the Department of Health and Human Services (DHHS) has dramatically reduced staff at the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Food and Drug Administration (FDA) and other federal health agencies. Word of the cuts—which are expected to include 10,000 people—came early Tuesday morning, shortly before Health Secretary Robert F.
New Long-Acting Integrase and Capsid Inhibitors Are on the Horizon

3 weeks ago | poz.com | Liz Highleyman

Two new HIV antiretrovirals with a high barrier to resistance—a next-generation integrase inhibitor and a capsid inhibitor from ViiV Healthcare—look promising in early studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) this month in San Francisco.
Nerve-Sparing Prostate Cancer Surgery Preserves Sexual Function

4 weeks ago | cancerhealth.com | Liz Highleyman

A robot-assisted surgery technique, dubbed NeuroSAFE, spares nerves and helps avoid erectile dysfunction in men undergoing treatment for prostate cancer, according to study findings presented at the 2025 European Association of Urology Congress and published in The Lancet Oncology.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
Tweets
DMs Open

Liz Highleyman @LizHighleyman

12 Apr 25

Never seen one of these before… https://t.co/8gHL0LCI1I

Liz Highleyman @LizHighleyman

11 Apr 25

When you think things can’t get any more absurd…

WIRED @WIRED

SCOOP: The Social Security Administration (SSA) will be shifting its public communication exclusively to X, sources tell WIRED. This comes as agency plans to cut its regional office workforce by roughly 90 percent. https://t.co/Xa8o4JuXnY

Liz Highleyman @LizHighleyman

11 Apr 25

RT @MichaelRLowry: It's hard to overstate how catastrophic this would be for hurricane forecasts. Should Congress approve the move, it woul…